A clinical and pharmacologic assessment of once-daily versus twice-daily dosing for rivaroxaban.
about
New Insights into the Pros and Cons of the Clinical Use of Vitamin K Antagonists (VKAs) Versus Direct Oral Anticoagulants (DOACs)Retrospective Evaluation of Postoperative Bleeding Events in Patients Receiving Rivaroxaban After Undergoing Total Hip and Total Knee Arthroplasty: Comparison with Clinical Trial Data.A novel, rapid method to compare the therapeutic windows of oral anticoagulants using the Hill coefficient.Efficacy and safety of rivaroxaban in real-life patients with atrial fibrillation.Effective practical management of patients with atrial fibrillation when using new oral anticoagulants.Direct Oral Anticoagulants for the Management of Thromboembolic Disorders: The Importance of Adherence and Persistence in Achieving Beneficial Outcomes.Evidence-Based Development and Rationale for Once-Daily Rivaroxaban Dosing Regimens Across Multiple Indications.The contribution of apixaban renal clearance to total clearance.Dissociation between the pharmacokinetics and pharmacodynamics of once-daily rivaroxaban and twice-daily apixaban: a randomized crossover study.The use of rivaroxaban for the treatment of thrombotic complications in four dogs.Practical perspectives on the use of non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with nonvalvular atrial fibrillation: A view from the Middle East and North Africa.
P2860
Q28081366-37E99DED-FB61-45A1-86E1-98C8ED0F611EQ30975631-4EB677E6-5812-4C70-A7AE-1AB8A0A98773Q37112747-59EA0718-5873-4949-93CD-D20E4AE2FDA3Q38386998-3268694B-2DEE-4515-9C61-B85DFD4C7CB2Q38409730-7B840F71-DA79-4BB9-88CC-ED028274891FQ38575711-31EED38E-3420-421D-B6F1-63B514AD7662Q38740354-D8993257-A5F1-45AA-89DF-62AAA4EE1A57Q43239260-51EDDE2C-A25C-47D4-B721-CEC816CCB23AQ50504217-288F445B-96CA-434F-90C6-C6E18BA03289Q50868752-88F4CB83-A883-4765-B6D9-9C00D6D576C6Q55222788-410AAB61-780F-4C4A-8CA9-2897E79DF71D
P2860
A clinical and pharmacologic assessment of once-daily versus twice-daily dosing for rivaroxaban.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
A clinical and pharmacologic a ...... -daily dosing for rivaroxaban.
@en
type
label
A clinical and pharmacologic a ...... -daily dosing for rivaroxaban.
@en
prefLabel
A clinical and pharmacologic a ...... -daily dosing for rivaroxaban.
@en
P2860
P1476
A clinical and pharmacologic a ...... e-daily dosing for rivaroxaban
@en
P2093
Reinhold Kreutz
P2860
P2888
P304
P356
10.1007/S11239-013-1029-2
P50
P577
2014-01-01T00:00:00Z